SIGA Technologies, Inc. (SIGA)
NASDAQ • Healthcare
Last close at October 22, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, SIGA Technologies, Inc. keeps $30 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 5
in 14 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Operating cash flow was about $15.2 million in the second fiscal quarter of 2026, results SIGA Technologies reported on August 6, 2026. SIGA, which is centered on biodefense antiviral therapeutics led by TPOXX, also returned cash to shareholders during the quarter, paying roughly $43.1 million in dividends and repurchasing about $0.0 million of stock.
Next report — what to expect
SIGA Technologies, Inc. (SIGA) is due to report its next quarterly results on an unknown date. Consensus EPS is n/a and consensus revenue is n/a. For trailing context, revenue declined -49.5% year over year last quarter. There isn’t enough history to characterize a recent beat/miss track record.
About SIGA Technologies, Inc.
SIGA Technologies, Inc. develops antiviral therapeutics in the healthcare sector and trades on the NASDAQ Global Market under the ticker SIGA. The company is a specialty drug maker centered on biodefense and infectious-disease treatment, with $94.6 million in revenue in FY2025.
Today's Snapshot
SIGA closed 1% above yesterday's close, in line with a firmer sector. Shares changed hands at about half of its usual level. SIGA is due to report earnings on 5 November.
Trading Volume
Below 10d avg (422.1K)
202.5K
vs S&P 500 Today
Outperforming Market
+2.22%
Updated: October 22, 2026 at 20:26 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$3.17 - $4.50Sell
- RSI (14)46.26Neutral
- Stochastic %K (14, 3, 3)15.62Buy
- MACD Level (12, 26)-0.02Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.